BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gouyou B, Grün K, Kerschenmeyer A, Villa A, Matasci M, Schrepper A, Pfeil A, Bäz L, Jung C, Schulze PC, Neri D, Franz M. Therapeutic Evaluation of Antibody-Based Targeted Delivery of Interleukin 9 in Experimental Pulmonary Hypertension. Int J Mol Sci 2021;22:3460. [PMID: 33801620 DOI: 10.3390/ijms22073460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu YC, Liang B, Gu N. Cellular and Molecular Mechanism of Traditional Chinese Medicine on Ventricular Remodeling. Front Cardiovasc Med 2021;8:753095. [PMID: 34926607 DOI: 10.3389/fcvm.2021.753095] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Silver AB, Leonard EK, Gould JR, Spangler JB. Engineered antibody fusion proteins for targeted disease therapy. Trends Pharmacol Sci 2021;42:1064-81. [PMID: 34706833 DOI: 10.1016/j.tips.2021.09.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yao X, Jing T, Wang T, Gu C, Chen X, Chen F, Feng H, Zhao H, Chen D, Ma W. Molecular Characterization and Elucidation of Pathways to Identify Novel Therapeutic Targets in Pulmonary Arterial Hypertension. Front Physiol 2021;12:694702. [PMID: 34366885 DOI: 10.3389/fphys.2021.694702] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Bäz L, Roßberg M, Grün K, Kretzschmar D, Berndt A, Schulze PC, Jung C, Franz M. Serum Liberation of Fetal Fibronectin Variants in Patients with Pulmonary Hypertension: ED-A+ Fn as Promising Novel Biomarker of Pulmonary Vascular and Right Ventricular Myocardial Remodeling. J Clin Med 2021;10:2559. [PMID: 34207881 DOI: 10.3390/jcm10122559] [Reference Citation Analysis]